Close Menu

NEW YORK – CureDuchenne has partnered with the University of California, Irvine, and RUCDR Infinite Biologics on a biobanking project.

CureDuchenne said in a statement it would begin collecting blood and skin samples from volunteer patients with Duchenne muscular dystrophy at its events around the US. When possible, it will also collect samples from "unaffected immediate blood relatives" including parents, siblings, and adult children.

Financial and other details were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.